Citi Pharma (KAR:CPHL) Days Payable: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:CPHL Citi Pharma Ltd KAR:CPHL
15 GF Score
Price ₨75.08
! 1 Warning Sign
View Full Analysis

What is Citi Pharma Days Payable?

Citi Pharma KAR:CPHL +0.37% 15 Days Payable is 0.00 as of . 20. GuruFocus rates KAR:CPHL with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 927 Drug Manufacturers companies, Citi Pharma ranks worse than 107874.76% on this metric.

Citi Pharma's average Accounts Payable for the six months ended in . 20 was ₨0.00 Mil. Citi Pharma's Cost of Goods Sold for the six months ended in . 20 was ₨0.00 Mil.

The historical rank and industry rank for Citi Pharma's Days Payable or its related term are showing as below:

KAR:CPHL's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.38
* Ranked among companies with meaningful Days Payable only.

Citi Pharma's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00).

Citi Pharma Days Payable Historical Data

* Premium members only.

The historical data trend for Citi Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citi Pharma Days Payable Chart

Citi Pharma Annual Data
Trend
Days Payable

Citi Pharma Semi-Annual Data
Days Payable

KAR:CPHL vs ZTS, UTHR, VTRS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Citi Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citi Pharma Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citi Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Citi Pharma's Days Payable falls into.


KAR:CPHL
15GF Score
Citi Pharma Ltd KAR:CPHL
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Citi Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Citi Pharma's Days Payable for the fiscal year that ended in . 20 is calculated as

Days Payable (A: . 20 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Citi Pharma's Days Payable for the quarter that ended in . 20 is calculated as:

Days Payable (Q: . 20 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: . 20 ) + Accounts Payable (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 2
=0 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Citi Pharma (KAR:CPHL) has a Days Payable of 0.00 as of . 20. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Citi Pharma and its competitors. According to the industry distribution chart, Citi Pharma ranks #999999 out of 927 companies in the Drug Manufacturers industry.
Is Citi Pharma's Days Payable too high?
Citi Pharma's current Days Payable is 0.00. Based on the distribution chart, Citi Pharma ranks #999999 out of 927 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Citi Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Citi Pharma's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Citi Pharma ranks #999999 out of 927 companies for Days Payable. This places Citi Pharma in the lower half of its industry. The industry median Days Payable is 90.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Citi Pharma and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Citi Pharma's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citi Pharma stock overvalued right now?
Citi Pharma (KAR:CPHL) has a current Days Payable of 0.00. The current Days Payable is 0.00. Citi Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Citi Pharma (KAR:CPHL), the current Days Payable is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Citi Pharma Business Description

Address 588 Q Block, M.A., Johar Town, Lahore, PB, PAK
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its product portfolio includes API segment, Formulation segment, Cephalosporin formulation, and Nutraceuticals. The API segment includes Paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, and Ibuprofen.
15GF Score

Get the complete analysis for KAR:CPHL

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨75.08
Price